Findings published earlier in 2015 in teh prestigious journal Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs developed by Oak Crest scientists shows extreme promise in stopping the spread of HIV. The report received extensive, international news coverage, including a special feature on Crown City News, a Pasadena-based news station.
